Market Research Logo

TBG Diagnostics Ltd (TDL) - Financial and Strategic SWOT Analysis Review

TBG Diagnostics Ltd (TDL) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include nucleic acid extraction kits, HLA SBT typing kits, HPA genotyping kits, automated pipetting system, and gel electrophoresis. It serves clinical laboratories of hospitals and independent reference labs, blood centers and bone marrow registry labs worldwide. It has research and development (R&D) facilities in the US, Taiwan and China and a manufacturing facility in Xiamen, China. The company has collaboration and product licensing agreements with various pharmaceutical companies and others to expand market presence and product portfolio. TBG Diagnostics is headquartered in Greenslopes, Queensland, Australia.

TBG Diagnostics Ltd Key Recent Developments

Apr 26,2018: TBG Diagnostics: Director Appointment /Resignation
Jul 24,2017: TBG ExProbe TM Real Time PCR Based Typing Kit receives Taiwan FDA approval and CE Mark, immediately opens markets
Jul 19,2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
TBG Diagnostics Ltd - Key Facts
TBG Diagnostics Ltd - Key Employees
TBG Diagnostics Ltd - Key Employee Biographies
TBG Diagnostics Ltd - Major Products and Services
TBG Diagnostics Ltd - History
TBG Diagnostics Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
TBG Diagnostics Ltd - Business Description
TBG Diagnostics Ltd - Corporate Strategy
TBG Diagnostics Ltd - SWOT Analysis
SWOT Analysis - Overview
TBG Diagnostics Ltd - Strengths
TBG Diagnostics Ltd - Weaknesses
TBG Diagnostics Ltd - Opportunities
TBG Diagnostics Ltd - Threats
TBG Diagnostics Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s, Lifesciences Financial Deals and Alliances
TBG Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018
TBG Diagnostics Ltd, Medical Equipment, Deals By Type, 2012 to YTD 2018
TBG Diagnostics Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 26, 2018: TBG Diagnostics: Director Appointment /Resignation
Jul 19, 2017: TBG Diagnostics Received ASHI accreditation for Xiamen facility
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
TBG Diagnostics Ltd, Key Facts
TBG Diagnostics Ltd, Key Employees
TBG Diagnostics Ltd, Key Employee Biographies
TBG Diagnostics Ltd, Major Products and Services
TBG Diagnostics Ltd, History
TBG Diagnostics Ltd, Other Locations
TBG Diagnostics Ltd, Subsidiaries
TBG Diagnostics Ltd, Key Competitors
TBG Diagnostics Ltd, Ratios based on current share price
TBG Diagnostics Ltd, Annual Ratios
TBG Diagnostics Ltd, Annual Ratios (Cont...1)
TBG Diagnostics Ltd, Interim Ratios
TBG Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018
TBG Diagnostics Ltd, Medical Equipment, Deals By Type, 2012 to YTD 2018
TBG Diagnostics Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
TBG Diagnostics Ltd, Performance Chart (2013 - 2017)
TBG Diagnostics Ltd, Ratio Charts
TBG Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018
TBG Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report